The Healthy, Aging, and Diseased Kidney: Relationship with Cardiovascular Disease.
acute kidney injury
cardiorenal syndrome
cardiovascular risk
chronic kidney disease
renal aging kidney
Journal
Journal of the American Geriatrics Society
ISSN: 1532-5415
Titre abrégé: J Am Geriatr Soc
Pays: United States
ID NLM: 7503062
Informations de publication
Date de publication:
02 2021
02 2021
Historique:
received:
24
02
2020
revised:
04
09
2020
accepted:
09
09
2020
pubmed:
27
10
2020
medline:
18
9
2021
entrez:
26
10
2020
Statut:
ppublish
Résumé
The cardiovascular and renal systems share an intimate physiological relationship, wherein a perturbance in one system may have an adverse effect on the other. Since the burden of renal disease increases with age, there is a considerable interest in the pathophysiology of kidney disease in the geriatric patient population. This review will explore the physiological dynamics behind the increased susceptibility to kidney disease in this population. A better understanding of these pathophysiological changes may lead to improved prevention and management strategies.
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
539-546Informations de copyright
© 2020 The American Geriatrics Society.
Références
Schiffrin EL, Lipman ML, Mann JF. Chronic kidney disease: effects on the cardiovascular system. Circulation. 2007;116(1):85-97.
Hoy WE, Douglas-Denton RN, Hughson MD, Cass A, Johnson K, Bertram JF. A stereological study of glomerular number and volume: preliminary findings in a multiracial study of kidneys at autopsy. Kidney Int. 2003;63:S31-S37.
Rule AD, Amer H, Cornell LD, et al. The association between age and nephrosclerosis on renal biopsy among healthy adults. Ann Intern Med. 2010;152(9):561-567.
Smeets B, Uhlig S, Fuss A, et al. Tracing the origin of glomerular extracapillary lesions from parietal epithelial cells. J Am Soc Nephrol. 2009;20(12):2604-2615.
Madias NE. Hemodynamically mediated glomerular injury and the progressive nature of kidney disease. Kidney Int. 1983;23:647-655.
Bohle A, Mackensen-Haen S, Gise H. Significance of tubulointerstitial changes in the renal cortex for the excretory function and concentration ability of the kidney: a morphometric contribution. Am J Nephrol. 1987;7(6):421-433.
Tanaka T, Kato H, Kojima I, et al. Hypoxia and expression of hypoxia-inducible factor in the aging kidney. J Gerontol A Biol Sci Med Sci. 2006;61(8):795-805.
Davies DF, Shock NW. Age changes in glomerular filtration rate, effective renal plasma flow, and tubular excretory capacity in adult males. J Clin Invest. 1950;29(5):496-507.
Bolignano D, Mattace-Raso F, Sijbrands EJG, Zoccali C. The aging kidney revisited: a systematic review. Ageing Res Rev. 2014;14:65-80.
Muslem R, Caliskan K, Akin S, et al. Effect of age and renal function on survival after left ventricular assist device implantation. Am J Cardiol. 2017;120(12):2221-2225.
Denegri A, Mehran R, Holy E, et al. Post procedural risk assessment in patients undergoing trans aortic valve implantation according to the age, creatinine, and ejection fraction-7 score: advantages of age, creatinine, and ejection fraction-7 in stratification of post-procedural outcome. Catheter Cardiovasc Interv. 2019;93(1):141-148.
Weinstein JR, Anderson S. The aging kidney: physiological changes. Adv Chronic Kidney Dis. 2010;17(4):302-307.
Baylis C. Sexual dimorphism in the aging kidney: differences in the nitric oxide system. Nat Rev Nephrol. 2009;5(7):384-396.
Alvis BD, Hughes CG. Physiology considerations in geriatric patients. Anesthesiol Clin. 2015;33(3):447-456.
Cardani R, Zavanella T. Age-related cell proliferation and apoptosis in the kidney of male Fischer 344 rats with observations on a spontaneous tubular cell adenoma. Toxicol Pathol. 2000;28(6):802-806.
Meyer TE. The ESCAPE trial. Curr Cardiol Rep. 2006;8(3):201-203.
Famulski KS, Halloran PF. Molecular events in kidney ageing. Curr Opin Nephrol Hypertens. 2005;14(3):243-248.
Sachdeva A, Weder AB. Nocturnal sodium excretion, blood pressure dipping, and sodium sensitivity. Hypertension. 2006;48(4):527-533.
OʼBrien E, Sheridan J, OʼMalley K. Dippers and non-dippers. Lancet. 1988;2(8607):397.
Pickering TG. The clinical significance of diurnal blood pressure variations: dippers and nondippers. Circulation. 1990;81(2):700-702.
Mahabala C, Kamath P, Bhaskaran U, Pai ND, Pai AU. Antihypertensive therapy: nocturnal dippers and nondippers: do we treat them differently? Vasc Health Risk Manag. 2013;9:125-133.
Douma LG, Holzworth MR, Solocinski K, et al. Renal Na-handling defect associated with PER1-dependent nondipping hypertension in male mice. Am J Physiol Renal Physiol. 2018;314(6):F1138-F1144.
Richards J, Ko B, All S, Cheng KY, Hoover RS, Gumz ML. A role for the circadian clock protein Per1 in the regulation of the NaCl co-transporter (NCC) and the with-no-lysine kinase (WNK) cascade in mouse distal convoluted tubule cells. J Biol Chem. 2014;289(17):11791-11806.
Stratton JR, Levy WC, Cerqueira MD, Schwartz RS, Abrass IB. Cardiovascular responses to exercise: effects of aging and exercise training in healthy men. Circulation. 1994;89(4):1648-1655.
Fleg JL, O'Connor F, Gerstenblith G et al. Impact of age on the cardiovascular response to dynamic upright exercise in healthy men and women. J Appl Physiol (1985). 1995;78(3):890-900.
Altenkirch HU, Gerzer R, Kirsch KA, et al. Effect of prolonged physical exercise on fluid regulating hormones. Eur J Appl Physiol Occup Physiol. 1990;61(3-4):209-213.
Rangaswami J, Bhalla V, Blair JEA, et al. Cardiorenal syndrome: classification, pathophysiology, diagnosis, and treatment strategies: a scientific statement from the American Heart Association. Circulation. 2019;139(16):e840-e878.
Nohria A, Hasselblad V, Stebbins A, et al. Cardiorenal interactions: insights from the ESCAPE trial. J Am Coll Cardiol. 2008;51(13):1268-1274.
Legrand M, Rossignol P. Cardiovascular consequences of acute kidney injury. N Engl J Med. 2020;382(23):2238-2247.
Mavrakanas TA, Khattak A, Singh K, Charytan DM. Epidemiology and natural history of the cardiorenal syndromes in a cohort with echocardiography. Clin J Am Soc Nephrol. 2017;12(10):1624-1633.
Levey AS, James MT. Acute kidney injury. Ann Intern Med. 2017;167(9):ITC66-ITC80.
Abdel-Kader K, Palevsky PM. Acute kidney injury in the elderly. Clin Geriatr Med. 2009;25(3):331-358.
Tsai HS, Chen YC, Chu PH. The influence of acute kidney injury on acute cardiovascular disease. Zhonghua Minguo Xin Zang Xue Hui Za Zhi. 2014;30(2):93-97.
Cunha BA. Pneumonia in the elderly. Clin Microbiol Infect. 2001;7(11):581-588.
Li Q, Zhao M, Wang X. The impact of transient and persistent acute kidney injury on short-term outcomes in very elderly patients. Clin Interv Aging. 2017;12:1013-1020.
Said S, Hernandez GT. The link between chronic kidney disease and cardiovascular disease. J Nephropathol. 2014;3(3):99-104.
Liu M, Li XC, Lu L, et al. Cardiovascular disease and its relationship with chronic kidney disease. Eur Rev Med Pharmacol Sci. 2014;18(19):2918-2926.
Karwowski W, Naumnik B, Szczepański M, Myśliwiec M. The mechanism of vascular calcification: a systematic review. Med Sci Monit. 2012;18(1):RA1-RA11.
Goodman WG. Vascular calcification in end-stage renal disease. J Nephrol. 2002;15(suppl 6):S82-S85.
Bikle DD. Vitamin D metabolism, mechanism of action, and clinical applications. Chem Biol. 2014;21(3):319-329.
Ballinger AE, Palmer SC, Nistor I, Craig JC, Strippoli GF. Calcimimetics for secondary hyperparathyroidism in chronic kidney disease patients. Cochrane Database Syst Rev. 2014;(12):CD006254.
Kaysen GA, Eiserich JP. The role of oxidative stress-altered lipoprotein structure and function and microinflammation on cardiovascular risk in patients with minor renal dysfunction. J Am Soc Nephrol. 2004;15(3):538-548.
Nakano T, Katsuki S, Chen M, et al. Uremic toxin indoxyl sulfate promotes proinflammatory macrophage activation via the interplay of OATP2B1 and Dll4-notch signaling. Circulation. 2019;139(1):78-96.
Menon V, Greene TOM, Wang X, et al. C-reactive protein and albumin as predictors of all-cause and cardiovascular mortality in chronic kidney disease. Kidney Int. 2005;68(2):766-772.
Clearfield MB. C-reactive protein: a new risk assessment tool for cardiovascular disease. J Am Osteopath Assoc. 2005;105(9):409-416.
Totzeck M, Hendgen-Cotta UB, Rassaf T. Nitrite-nitric oxide signaling and cardioprotection. Adv Exp Med Biol. 2017;982:335-346.
Sarnak MJ, Bloom R, Muntner P, et al. KDOQI US commentary on the 2013 KDIGO clinical practice guideline for lipid management in CKD. Am J Kidney Dis. 2015;65(3):354-366.
Matsushita K, Ballew SH, Coresh J, et al. Measures of chronic kidney disease and risk of incident peripheral artery disease: a collaborative meta-analysis of individual participant data. Lancet Diabetes Endocrinol. 2017;5(9):718-728.
Peev V, Nayer A, Contreras G. Dyslipidemia, malnutrition, inflammation, cardiovascular disease and mortality in chronic kidney disease. Curr Opin Lipidol. 2014;25(1):54-60.